The FDA has found problems at an Indian factory that makes generic drugs for American patients, including one medication that was manufactured there and has been linked to at least eight deaths, federal records show. The agency inspected the factory after a ProPublica investigation in December found that the plant, operated by Glenmark Pharmaceuticals, was responsible for an outsized share of recalls for pills that didn't dissolve properly and could harm people.
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that would have members of the Sackler family who own the company pay up to $7 billion. The filing is a milestone in a tumultuous legal saga that has gone on for more than five years.
Thousands of employees returned to the FDA's headquarters Monday to find overflowing parking lots, long security lines and makeshift office spaces without chairs and other basic supplies. The FDA is the latest agency scrambling to meet the Trump administration's return-to-office mandate, part of a flurry of actions — including firings and buyouts — intended to radically shrink the federal workforce. Monday was the first day that all rank-and-file FDA staffers were required to report to offices, including the agency's 130-acre campus just outside Washington.
The number of measles cases associated with an outbreak in western Texas has grown to 259, with 36 cases reported over the last three days, according to new data released Friday. Almost all of the cases are in unvaccinated individuals or in individuals whose vaccination status is unknown. Two cases have occurred in persons vaccinated with two doses, according to the Texas Department of State Health Services. Breakthrough infections, when a vaccinated person is infected are rare, as the measles vaccine provides up to 97% protection after 2 doses.
President Donald Trump abruptly yanked his nominee to head the CDC on Thursday morning shortly before a scheduled Senate confirmation hearing. A source familiar with the discussions said Trump pulled David Weldon's nomination because he did not have the votes to be confirmed.
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision filed late Wednesday, Judge Mark Pittman of the Northern District of Texas declined to issue an injunction to stop the FDA from declaring there was no longer a shortage of the medicines' active ingredient, tirzepatide.